Thought LeadersDr. Mohammad SafiarianAssociate Product ManagerSino Biological This interview with Dr. Mohammad S Safiarian, Associate Product Manager at Sino Biological, discusses the advances in ...

Overall, the study authors concluded that the immunogenicity of quadrivalent influenza vaccines (QIV) and trivalent inactivated influenza vaccines (TIV) was similar for common influenza ingredients ...

The seasonal influenza vaccine contains strains of viruses from distinct virus subtypes, but most people who are vaccinated will mount a strong immune response to one strain, leaving them vulnerable ...

Researchers found that the relative efficacy of the modRNA vaccine was 34.5% against influenza-like illness compared with the control vaccine, on the basis of 57 and 87 cases in the modRNA and control ...

In this prospective observational study, immune protection against H5N1 and H7N9 avian influenza virus (AIV) was almost absent prior to vaccination. However, seasonal influenza vaccines induced a ...

The relative efficacy of a modified mRNA vaccine as compared with the standard inactivated vaccine against influenza-like illness was 34.5%, meeting noninferiority and superiority. Those who received ...

Recent preclinical results indicate novel next-generation vaccine candidates protect against multiple strains of influenza and last longer than vaccines currently in use. Recent preclinical results ...

About The Study: This study found reduced incidence of cardiorespiratory hospitalization among those who received high-dose inactivated influenza vaccine vs standard-dose inactivated influenza vaccine ...

Among older adults, the incidence of myocarditis or pericarditis was lower among those who received the high-dose inactivated flu vaccine versus the standard-dose vaccine. There were only two cases of ...

Every year, millions of individuals are infected by the seasonal influenza virus, which results in hundreds of thousands of deaths worldwide. Vaccination is an effective approach used to prevent ...